Skip to main content
Journal cover image

PD-016 Current results of a phase I study of DKN-01 in combination with paclitaxel (P) in patients (pts) with advanced DKK1+ esophageal cancer (EC) or gastro-esophageal junction tumors (GEJ)

Publication ,  Conference
Ryan, DP; Murphy, J; Mahalingam, D; Strickler, J; Stein, S; Sirard, C; Landau, S; Bendell, J
Published in: Annals of Oncology
June 2016

Duke Scholars

Published In

Annals of Oncology

DOI

ISSN

0923-7534

Publication Date

June 2016

Volume

27

Start / End Page

ii108 / ii108

Publisher

Elsevier BV

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ryan, D. P., Murphy, J., Mahalingam, D., Strickler, J., Stein, S., Sirard, C., … Bendell, J. (2016). PD-016 Current results of a phase I study of DKN-01 in combination with paclitaxel (P) in patients (pts) with advanced DKK1+ esophageal cancer (EC) or gastro-esophageal junction tumors (GEJ). In Annals of Oncology (Vol. 27, pp. ii108–ii108). Elsevier BV. https://doi.org/10.1093/annonc/mdw200.16
Ryan, D. P., J. Murphy, D. Mahalingam, J. Strickler, S. Stein, C. Sirard, S. Landau, and J. Bendell. “PD-016 Current results of a phase I study of DKN-01 in combination with paclitaxel (P) in patients (pts) with advanced DKK1+ esophageal cancer (EC) or gastro-esophageal junction tumors (GEJ).” In Annals of Oncology, 27:ii108–ii108. Elsevier BV, 2016. https://doi.org/10.1093/annonc/mdw200.16.
Ryan DP, Murphy J, Mahalingam D, Strickler J, Stein S, Sirard C, et al. PD-016 Current results of a phase I study of DKN-01 in combination with paclitaxel (P) in patients (pts) with advanced DKK1+ esophageal cancer (EC) or gastro-esophageal junction tumors (GEJ). In: Annals of Oncology. Elsevier BV; 2016. p. ii108–ii108.
Ryan, D. P., et al. “PD-016 Current results of a phase I study of DKN-01 in combination with paclitaxel (P) in patients (pts) with advanced DKK1+ esophageal cancer (EC) or gastro-esophageal junction tumors (GEJ).” Annals of Oncology, vol. 27, Elsevier BV, 2016, pp. ii108–ii108. Crossref, doi:10.1093/annonc/mdw200.16.
Ryan DP, Murphy J, Mahalingam D, Strickler J, Stein S, Sirard C, Landau S, Bendell J. PD-016 Current results of a phase I study of DKN-01 in combination with paclitaxel (P) in patients (pts) with advanced DKK1+ esophageal cancer (EC) or gastro-esophageal junction tumors (GEJ). Annals of Oncology. Elsevier BV; 2016. p. ii108–ii108.
Journal cover image

Published In

Annals of Oncology

DOI

ISSN

0923-7534

Publication Date

June 2016

Volume

27

Start / End Page

ii108 / ii108

Publisher

Elsevier BV

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis